Antioxidant potential of chlorogenic acid in Age-Related eye diseases.

Authors:
Tang Y; Fang C; Shi J; Chen H; Chen X and 1 more

Journal:
Pharmacol Res Perspect

Publication Year: 2024

DOI:
10.1002/prp2.1162

PMCID:
PMC10772849

PMID:
38189160

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Pharmacol Res Perspect

Abbreviation: Pharmacol Res Perspect

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
2-Deoxyglucose and hydroxychloroquine HPLC-MS-MS analytical methods and pharmacokinetic interaction…
Sun D; Kim S; Karelia D and 3 more (2024) - Transparency Score: 3/6
A descriptive pharmacokinetic/pharmacodynamic analysis of ceftazidime-avibactam in a case series of…
Xu Y; Tang J; Yuan B and 7 more (2024) - Transparency Score: 3/6
Adherence to newer second-line oral antidiabetic drugs among people with type 2 diabetes-A systemat…
Holdt-Caspersen NS; Dethlefsen C; Vestergaard P and 3 more (2024) - Transparency Score: 5/6
A systematic review on experimental studies about patient adherence to treatment.
Folkvord F; Würth AR; van Houten K and 23 more (2024) - Transparency Score: 3/6
Clinical considerations on monkeypox antiviral medications: An overview.
Pourkarim F; Entezari-Maleki T. (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest."

Evidence found in paper:

"This work is supported by the National Natural Science Foundation of China (82174443), the Natural Science Foundation of Hunan Province of China (2021JJ30527), the Key Project of Educational Commission of Hunan Province of China (20A370), and the Key Program of Administration of Chinese Medicine of Hunan Province of China (2021023). Figure 3 is modified from Servier Medical Art (http://smart.servier.com/), licensed under a Creative Common Attribution 3.0 Generic License. (https://creativecommons.org/licenses/by/3.0/)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025